Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK39297 in Primary IgA Nephropathy
NCT07616700Phase 2Recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Aug 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 2 trial of ciprocopan in IgA nephropathy (IgAN), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Aug 2025; status: recruiting.
02
Drugs
ciprocopan
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT07616700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07616700.